Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G/A for SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value (SABS).
- Disclosed ownership: 3.2%.
- Date of event: 31 Dec 2025.
RTW INVESTMENTS, LP - 31 Dec 2025 SCHEDULE 13G/A Report for SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value (SABS)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- SABS
- Shares outstanding
- 49,603,188 shares
- Disclosed Ownership
- 1,587,302 shares
- Ownership
- 3.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 08:47:19 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 3.2% ownership in SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value (SABS) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 17 Feb 2026, 08:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 3.2% | 1,587,302 | 0 | 1,587,302 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong | 3.2% | 1,587,302 | 0 | 1,587,302 | s/ Roderick Wong, M.D. | Roderick Wong, M.D. |